From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Clinical data
Synonyms D5159; 6α,9α-Difluoro-11β,16α,17α-trihydroxy-21-oxa-3-oxoandrosta-1,4-diene-17β-carboxylic acid, ester with ethyl (S)-1-hydroxyethyl carbonate, cyclic (R)-16,17-acetal with butyraldehyde; 6α,9α-Difluoro-11β,16α,17α-trihydroxy-21-oxapregna-1,4-diene-3,20-dione 21-(1-[(ethoxycarbonyl)oxy]ethyl), cyclic (R)-16,17-acetal with butyraldehyde
Drug class Corticosteroid; Glucocorticoid
CAS Number
  • 106033-96-9
PubChem CID
  • 9959691
  • 8135300
  • 2ZW8NEP6PQ
  • ChEMBL2105863
Chemical and physical data
Formula C29H38F2O9
Molar mass 568.61 g·mol−1
3D model (JSmol)
  • Interactive image

Itrocinonide (developmental code name D5159) is a synthetic glucocorticoid corticosteroid which was never marketed.[1][2][3]


  1. ^ Nicholas Bodor; Peter Buchwald (29 August 2012). Retrometabolic Drug Design and Targeting. John Wiley & Sons. pp. 193–. ISBN 978-1-118-40776-9.
  2. ^ Robert P. Schleimer (19 April 2016). Inhaled Steroids in Asthma: Optimizing Effects in the Airways. CRC Press. pp. 526–. ISBN 978-0-203-90853-2.
  3. ^ Trevor T. Hansel; Peter J. Barnes (1 January 2001). New Drugs for Asthma, Allergy and COPD. Karger Medical and Scientific Publishers. pp. 95–. ISBN 978-3-8055-6862-3.

Retrieved from ""
This content was retrieved from Wikipedia :
This page is based on the copyrighted Wikipedia article "Itrocinonide"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA